MoneyWorks4Me

Laurus Labs informs about board meeting

20 Oct 2021 Evaluate
Laurus Labs has informed that the meeting of the Board of Directors of the Company is scheduled on 28/10/2021 to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021; to consider the proposal for payment of Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.50
Dr. Reddys Labs. 1220.40
Cipla 1322.70
Lupin 1955.65
Zydus Lifesciences 1129.00
View more..